1. Home
  2. IMRN vs ARTW Comparison

IMRN vs ARTW Comparison

Compare IMRN & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • ARTW
  • Stock Information
  • Founded
  • IMRN 1994
  • ARTW 1956
  • Country
  • IMRN Australia
  • ARTW United States
  • Employees
  • IMRN N/A
  • ARTW N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • ARTW Industrial Machinery/Components
  • Sector
  • IMRN Health Care
  • ARTW Industrials
  • Exchange
  • IMRN Nasdaq
  • ARTW Nasdaq
  • Market Cap
  • IMRN 10.3M
  • ARTW 8.7M
  • IPO Year
  • IMRN N/A
  • ARTW N/A
  • Fundamental
  • Price
  • IMRN $1.71
  • ARTW $1.80
  • Analyst Decision
  • IMRN Strong Buy
  • ARTW
  • Analyst Count
  • IMRN 1
  • ARTW 0
  • Target Price
  • IMRN $5.00
  • ARTW N/A
  • AVG Volume (30 Days)
  • IMRN 11.8K
  • ARTW 27.7K
  • Earning Date
  • IMRN 05-27-2025
  • ARTW 07-02-2025
  • Dividend Yield
  • IMRN N/A
  • ARTW N/A
  • EPS Growth
  • IMRN N/A
  • ARTW N/A
  • EPS
  • IMRN N/A
  • ARTW 0.14
  • Revenue
  • IMRN $4,048,286.00
  • ARTW $23,916,932.00
  • Revenue This Year
  • IMRN N/A
  • ARTW N/A
  • Revenue Next Year
  • IMRN N/A
  • ARTW N/A
  • P/E Ratio
  • IMRN N/A
  • ARTW $36.28
  • Revenue Growth
  • IMRN 82.90
  • ARTW N/A
  • 52 Week Low
  • IMRN $1.60
  • ARTW $1.33
  • 52 Week High
  • IMRN $2.87
  • ARTW $4.15
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 41.94
  • ARTW 60.15
  • Support Level
  • IMRN $1.87
  • ARTW $1.71
  • Resistance Level
  • IMRN $2.13
  • ARTW $1.86
  • Average True Range (ATR)
  • IMRN 0.15
  • ARTW 0.10
  • MACD
  • IMRN -0.01
  • ARTW 0.01
  • Stochastic Oscillator
  • IMRN 32.71
  • ARTW 80.00

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

Share on Social Networks: